Literature DB >> 20026955

Acute auditory and vestibular symptoms associated with heat and transdermal lidocaine.

Nima Shemirani1, Darryl Tang, David R Friedland.   

Abstract

OBJECTIVES: To describe a case of systemic lidocaine toxicity from the simultaneous use of transdermal patches and a heating pad.
METHODS: Case report and discussion.
RESULTS: The focus of this case report are the interesting neuro-otologic signs of central lidocaine toxicity that occurred after a patient fell asleep on a heating pad with his Lidoderm patches in place. Hearing improvement, tinnitus reduction, and severe dizziness and ataxia were present for approximately 48 hours before spontaneous resolution. Based upon his symptoms we estimate an 11-fold increase in plasma concentrations of lidocaine. DISCUSSION: Transdermal delivery of medication affords ease of application, ability to provide continuous pharmacological therapy, and ability to supply medication to the affected site. Due to the superficial application of these medications, external environmental factors may influence the pharmacokinetics of drug delivery. This case highlights the complications that can arise from the combination of heating pads and transdermal pain therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20026955     DOI: 10.1097/AJP.0b013e3181b2e84e

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  3 in total

1.  Patch Problems? Characteristics of Transdermal Drug Delivery System Exposures Reported to the National Poison Data System.

Authors:  Stephen L Thornton; Micheal A Darracq
Journal:  J Med Toxicol       Date:  2019-08-13

2.  Transdermal lidocaine as treatment for chronic subjective tinnitus: A pilot study.

Authors:  Daniel C O'Brien; Aaron D Robinson; Nancy Wang; Rodney Diaz
Journal:  Am J Otolaryngol       Date:  2019-03-18       Impact factor: 1.808

3.  Chronic Primary Tinnitus: A Management Dilemma.

Authors:  Annanya Soni; Abhishek Dubey
Journal:  Audiol Res       Date:  2020-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.